Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Pharmacology

  • 1
    News

    Consider Patient Safety, Outcomes Risk before Prescribing Off-Label Drugs

    December 2, 2012

    Once a drug has been approved for use, if, in your clinical judgment there are other indications for which it could be beneficial, then you are well within your rights to prescribe it

  • News

    Study: Collaborative Approach to Med Rec Effective, Cost-Efficient

    August 7, 2012

    Adverse-drug-event prevention is a “team game,” says researcher

  • News

    Report: Pharmacist-Led Interventions Don’t Reduce Medication Errors Post-Discharge

    August 1, 2012

    Unexpectedly low health literacy muted efficacy of post-discharge follow-ups, hospitalist says

  • 1
    News

    Collaboration Prevents Identification Band Errors

    July 31, 2012

    Can a quality-improvement collaborative decrease patient ID band errors?

  • News

    Reconciliation Act

    December 21, 2011

    “Med rec” translates to effective communication at every transition of care; experts say hospitalists should own the initiative

  • News

    Six Ways You Can Help Reduce HAIs in Your Hospital

    December 21, 2011

    Hospitalists can help prevent hospital-acquired infections

  • 1
    News

    Under the Microscope: Medication Reconciliation

    April 1, 2011

    $1.5M grant helps launch three-year, multisite QI project

  • News

    Market Watch

    November 1, 2010

    The latest news about new generics, indications, and safety information

  • News

    Market Watch

    October 1, 2010

    New generics, new indications, and safety information

  • News

    Market Watch

    August 2, 2010

    New Drugs, Indications, Dosage Forms, and Approvals Hydromorphone extended-release tablets (Exalgo) have been approved by the FDA as a once-daily treatment for managing moderate to severe pain in opioid-tolerant patients needing continuous opioid analgesia for an extended period of time.1 This f

Previous1 … 11 12 13 14Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences